Authors:
VANLAAR T
VANHILTEN B
NEEF C
RUTGERS AWF
PAVEL S
BRUIJN JA
Citation: T. Vanlaar et al., THE ROLE OF EDTA IN PROVOKING ALLERGIC REACTIONS TO SUBCUTANEOUS INFUSION OF APOMORPHINE IN PATIENTS WITH PARKINSONS-DISEASE - A HISTOLOGIC-STUDY, Movement disorders, 13(1), 1998, pp. 52-55
Authors:
VANLAAR T
VANDERGEEST R
DANHOF M
BODDE HE
GOOSSENS PH
ROOS RAC
Citation: T. Vanlaar et al., STEPWISE INTRAVENOUS-INFUSION OF APOMORPHINE TO DETERMINE THE THERAPEUTIC WINDOW IN PATIENTS WITH PARKINSONS-DISEASE, Clinical neuropharmacology, 21(3), 1998, pp. 152-158
Authors:
VANDERGEEST R
VANLAAR T
KRUGER PP
GUBBENSSTIBBE JM
BODDE HE
ROOS RAC
DANHOF M
Citation: R. Vandergeest et al., PHARMACOKINETICS, ENANTIOMER INTERCONVERSION, AND METABOLISM OF R-APOMORPHINE IN PATIENTS WITH IDIOPATHIC PARKINSONS-DISEASE, Clinical neuropharmacology, 21(3), 1998, pp. 159-168
Authors:
DANHOF M
VANDERGEEST R
VANLAAR T
BODDE HE
Citation: M. Danhof et al., AN INTEGRATED PHARMACOKINETIC-PHARMACODYNAMIC APPROACH TO OPTIMIZATION OF R-APOMORPHINE DELIVERY IN PARKINSONS-DISEASE, Advanced drug delivery reviews, 33(3), 1998, pp. 253-263
Authors:
VANDERGEEST R
KRUGER P
GUBBENSSTIBBE JM
VANLAAR T
BODDE HE
DANHOF M
Citation: R. Vandergeest et al., ASSAY OF R-APOMORPHINE, S-APOMORPHINE, APOCODEINE, ISOAPOCODEINE AND THEIR GLUCURONIDE AND SULFATE CONJUGATES IN PLASMA AND URINE OF PATIENTS WITH PARKINSONS-DISEASE, Journal of chromatography B. Biomedical sciences and applications, 702(1-2), 1997, pp. 131-141
Authors:
VANDERGEEST R
VANLAAR T
GUBBENSSTIBBE JM
BODDE HE
DANHOF M
Citation: R. Vandergeest et al., IONTOPHORETIC DELIVERY OF APOMORPHINE II - AN IN-VIVO STUDY IN PATIENTS WITH PARKINSONS-DISEASE, Pharmaceutical research, 14(12), 1997, pp. 1804-1810
Authors:
VANHILTEN JJ
WAGEMANS EAH
GHAFOERKHAN SF
VANLAAR T
Citation: Jj. Vanhilten et al., MOVEMENT CHARACTERISTICS IN PARKINSONS-DISEASE - DETERMINATION OF DOPAMINERGIC RESPONSIVENESS AND THRESHOLD, Clinical neuropharmacology, 20(5), 1997, pp. 402-408
Authors:
TERLETH C
VANLAAR T
SCHOUTEN R
VANSTEEG H
HODEMAEKERS H
WORMHOUDT T
CORNELISSENSTEIJGER PDM
ABRAHAMS PJ
VANDEREB AJ
Citation: C. Terleth et al., A LACK OF RADIATION-INDUCED ORNITHINE DECARBOXYLASE ACTIVITY PREVENTSENHANCED REACTIVATION OF HERPES-SIMPLEX VIRUS AND IS LINKED TO NONCANCER PRONENESS IN XERODERMA-PIGMENTOSUM PATIENTS, Cancer research, 57(19), 1997, pp. 4384-4392
Authors:
VANLAAR T
NEEF C
DANHOF M
ROON KI
ROOS RAC
Citation: T. Vanlaar et al., A NEW SUBLINGUAL FORMULATION OF APOMORPHINE IN THE TREATMENT OF PATIENTS WITH PARKINSONS-DISEASE, Movement disorders, 11(6), 1996, pp. 633-638
Authors:
WOLTERS EC
TESSELAAR HJM
BUSSEMAKER FEAM
DAMMERS JWHH
HAAS JA
HORSTINK MWIM
JANSEN ENH
KORTEN JJ
LAKKE JPWF
DECOUL AAWO
PEPERKAMP JPC
ROOS RAC
RUTGERS AWF
TIJSSEN CC
VANDERZWAN A
VANLAAR T
VANLEUSDEN JA
VANROSSUM J
VERBIEST HBC
VERMEIJ AJ
BAKHEIT J
BATES D
CAPILDEO R
CHAND J
KENNEDY P
LEES A
PARK D
STURMAN S
TURJANSKI N
WILLIAMS A
Citation: Ec. Wolters et al., INTERNATIONAL (NL-UK) DOUBLE-BLIND-STUDY OF SINEMET CR AND STANDARD SINEMET (25 100) IN 170 PATIENTS WITH FLUCTUATING PARKINSONS-DISEASE/, Journal of neurology, 243(3), 1996, pp. 235-240
Authors:
STEEGENGA WT
VANLAAR T
RITECO N
MANDARINO A
SHVARTS A
VANDEREB AJ
JOCHEMSEN AG
Citation: Wt. Steegenga et al., ADENOVIRUS E1A PROTEINS INHIBIT ACTIVATION OF TRANSCRIPTION BY P53, Molecular and cellular biology, 16(5), 1996, pp. 2101-2109
Authors:
VANLAAR T
SCHOUTEN R
JOCHEMSEN AG
TERLETH C
VANDEREB AJ
Citation: T. Vanlaar et al., TEMPERATURE-SENSITIVE MUTANT P53 (ALA143) INTERFERES TRANSIENTLY WITHDNA-SYNTHESIS AND CELL-CYCLE PROGRESSION IN SAOS-2 CELLS, Cytometry, 25(1), 1996, pp. 21-31
Citation: Epj. Arnoldus et T. Vanlaar, A REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME, The New England journal of medicine, 334(26), 1996, pp. 1745-1745
Authors:
STEEGENGA WT
SHVARTS A
VANLAAR T
VANDEREB AJ
JOCHEMSEN AG
Citation: Wt. Steegenga et al., ALTERED PHOSPHORYLATION AND OLIGOMERIZATION OF P53 IN ADENOVIRUS TYPE12-TRANSFORMED CELLS, Oncogene, 11(1), 1995, pp. 49-57
Authors:
ABRAHAMS PJ
SCHOUTEN R
VANLAAR T
HOUWELING A
TERLETH C
VANDEREB AJ
Citation: Pj. Abrahams et al., DIFFERENT REGULATION OF P53 STABILITY IN UV-IRRADIATED NORMAL AND DNA-REPAIR DEFICIENT HUMAN-CELLS, Mutation research. DNA repair, 336(2), 1995, pp. 169-180
Authors:
VANLAAR T
JANSEN ENH
NEEF C
DANHOF M
ROOS RAC
Citation: T. Vanlaar et al., PHARMACOKINETICS AND CLINICAL EFFICACY OF RECTAL APOMORPHINE IN PATIENTS WITH PARKINSONS-DISEASE - A STUDY OF 5 DIFFERENT SUPPOSITORIES, Movement disorders, 10(4), 1995, pp. 433-439
Authors:
STEEGENGA WT
VANLAAR T
SHVARTS A
TERLETH C
VANDEREB AJ
JOCHEMSEN AG
Citation: Wt. Steegenga et al., DISTINCT MODULATION OF P53 ACTIVITY IN TRANSCRIPTION AND CELL-CYCLE REGULATION BY THE LARGE (54 KDA) AND SMALL (21 KDA) ADENOVIRUS E1B PROTEINS, Virology, 212(2), 1995, pp. 543-554
Authors:
VANLAAR T
STEEGENGA WT
JOCHEMSEN AG
TERLETH C
VANDEREB AJ
Citation: T. Vanlaar et al., GM1492 HUMAN-DIPLOID SKIN FIBROBLASTS LACK THE P53-DEPENDENT G1 CELL-CYCLE CHECKPOINT, Biochemical and biophysical research communications, 217(3), 1995, pp. 769-776
Authors:
VANLAAR T
STEEGENGA WT
JOCHEMSEN AG
TERLETH C
VANDEREB AJ
Citation: T. Vanlaar et al., BLOOMS SYNDROME CELLS GM1492 LACK DETECTABLE P53 PROTEIN BUT EXHIBIT NORMAL G1 CELL-CYCLE ARREST AFTER UV IRRADIATION, Oncogene, 9(3), 1994, pp. 981-983
Citation: Dj. Hofstee et al., PHARMACOKINETICS OF APOMORPHINE IN PARKINSONS-DISEASE - PLASMA AND CEREBROSPINAL-FLUID LEVELS IN RELATION TO MOTOR-RESPONSES, Clinical neuropharmacology, 17(1), 1994, pp. 45-52
Authors:
VANLAAR T
JANSEN ENH
ESSINK AWG
NEEF C
OOSTERLOO S
ROOS RAC
Citation: T. Vanlaar et al., A DOUBLE-BLIND-STUDY OF THE EFFICACY OF APOMORPHINE AND ITS ASSESSMENT IN OFF-PERIODS IN PARKINSONS-DISEASE, Clinical neurology and neurosurgery, 95(3), 1993, pp. 231-235
Authors:
VANDENHEUVEL SJL
VANLAAR T
THE I
VANDEREB AJ
Citation: Sjl. Vandenheuvel et al., LARGE E1B PROTEINS OF ADENOVIRUS TYPE-5 AND TYPE-12 HAVE DIFFERENT EFFECTS ON P53 AND DISTINCT ROLES IN CELL-TRANSFORMATION, Journal of virology, 67(9), 1993, pp. 5226-5234